Canada won’t limit J&J COVID-19 vaccine access due to rare blood clots: Tam - National | Globalnews.ca

Canada News News

Canada won’t limit J&J COVID-19 vaccine access due to rare blood clots: Tam - National | Globalnews.ca
Canada Latest News,Canada Headlines
  • 📰 GlobalNational
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Canada won’t limit J&J COVID-19 vaccine access due to rare blood clots: Tam

Canada’s top doctor said Friday that there have been no cases of a rare blood clotting syndrome from Johnson & Johnson’s, Canada’s chief public health officer, said in a press conference that she doesn’t expect the Public Health Agency of Canada to change its recommendations on the vaccine. It was fully approved in Canada in November 2021.Her comments come after the U.S.

U.S. officials say that blood clots from the vaccine are rare but still occurring — of 60 cases reported as of mid-March, nine were fatal. The vaccine will now carry a more explicit warning in the U.S. on potential “long-term and debilitating health consequences.”Story continues below advertisement Tam, though, said that Canadian officials are satisfied with the current labeling and do not plan further changes. Canada updated the vaccine’s label in April 2021 to note the risk of blood clots, and again in November to add the autoimmune condition, immune thrombocytopenia , as a potential side effect.Tam noted that the vaccine has been administered to around 8 million recipients in the U.S.

However, she said the issue should still be considered. “Like any safety signal, it needs to be taken seriously.”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

GlobalNational /  🏆 81. in CA

Canada Latest News, Canada Headlines



Render Time: 2025-02-14 14:49:53